Literature DB >> 10583284

Hepatitis viral status in patients undergoing liver resection for hepatocellular carcinoma.

C C Wu1, W L Ho, J T Chen, J S Tang, D C Yeh, F K P'eng.   

Abstract

BACKGROUND: Hepatitis B and C viruses are the main causative agents of hepatocellular carcinoma (HCC). The influence of hepatitis viral status on liver resection for HCC remains undetermined.
METHODS: Patients who underwent curative resection for HCC were divided into four groups: group 1, seronegative for hepatitis B surface antigen (HBsAg) and antihepatitis C antibody (HCVAb); group 2, seropositive for HBsAg only; group 3, seropositive for HCVAb only; and group 4, seropositive for HBsAg and HCVAb. The clinicopathological characteristics and surgical results of the four groups were compared. Resection of HCC was determined according to liver functional reserve and tumour extent.
RESULTS: There were 40, 131, 70 and 20 patients in groups 1, 2, 3 and 4 respectively. Due to patient selection bias, there were significant differences in some background features, resectional extent and pathological characteristics among the four groups. Postoperative morbidity and mortality, as well as the Union Internacional Contra la Cancrum tumour node metastasis stages, did not differ. Patients in group 1 had a higher disease-free survival rate than those in group 2 (P = 0. 02). The actuarial survival rates of patients in groups 2 and 4 were lower than those of groups 1 and 3.
CONCLUSION: With careful patient selection, the hepatitis viral status does not influence the surgical risks of hepatectomy for HCC. After liver resection for HCC, the long-term survival rate of patients seronegative for HBsAg is greater than that of patients seropositive for HBsAg.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10583284     DOI: 10.1046/j.1365-2168.1999.01272.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  14 in total

1.  Hepatic resection is justified for elderly patients with hepatocellular carcinoma.

Authors:  Kazuhiro Kondo; Kazuo Chijiiwa; Mayumi Funagayama; Masahiro Kai; Kazuhiro Otani; Jiro Ohuchida
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

2.  Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B- or hepatitis C-related hepatocellular carcinoma.

Authors:  Yo Sasaki; Terumasa Yamada; Hideo Tanaka; Hiroaki Ohigashi; Hidetoshi Eguchi; Masahiko Yano; Osamu Ishikawa; Shingi Imaoka
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

3.  Hepatitis B or C virus serology as a prognostic factor in patients with hepatocellular carcinoma.

Authors:  S A Ahmad; M M Bilimoria; X Wang; F Izzo; P Delrio; P Marra; T P Baker; G A Porter; L M Ellis; J N Vauthey; S Dhamotharan; S A Curley
Journal:  J Gastrointest Surg       Date:  2001 Sep-Oct       Impact factor: 3.452

4.  The tumor marker score is an independent predictor of survival in patients with recurrent hepatocellular carcinoma.

Authors:  Yukiyasu Okamura; Ryo Ashida; Takaaki Ito; Teiichi Sugiura; Keita Mori; Katsuhiko Uesaka
Journal:  Surg Today       Date:  2014-12-20       Impact factor: 2.549

Review 5.  The prognostic significance of clinical and pathological features in hepatocellular carcinoma.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

6.  Differences in long-term outcome and prognostic factors according to viral status in patients with hepatocellular carcinoma treated by surgery.

Authors:  Kazuhiro Kondo; Kazuo Chijiiwa; Mayumi Funagayama; Masahiro Kai; Kazuhiro Otani; Jiro Ohuchida
Journal:  J Gastrointest Surg       Date:  2007-11-13       Impact factor: 3.452

7.  Twenty-year survivors after resection for hepatocellular carcinoma-analysis of 53 cases.

Authors:  Xin-Da Zhou; Zhao-You Tang; Zeng-Chen Ma; Jia Fan; Zhi-Quan Wu; Lun-Xiu Qin; Jian Zhou; Yao Yu; Hui-Chuan Sun; Shuang-Jian Qiu
Journal:  J Cancer Res Clin Oncol       Date:  2009-03-18       Impact factor: 4.553

Review 8.  Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-17       Impact factor: 4.553

9.  Clinical characteristics of hepatitis B core antibody-positive hepatocellular carcinoma.

Authors:  Takuya Nakai; Kenzo Koh; Takashi Kawabe; Osamu Shiraishi; Kiyotaka Okuno; Masayuki Yasutomi
Journal:  World J Surg       Date:  2002-03-26       Impact factor: 3.352

10.  Surgical results in patients with hepatitis virus-related hepatocellular carcinoma in Taiwan.

Authors:  Miin-Fu Chen; Long-Bin Jeng; Wei-Chen Lee
Journal:  World J Surg       Date:  2002-03-26       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.